Clinical AI Reimbursement — Payment Models, Policy Gaps, and Cost Concerns
OVERVIEWReimbursement remains a major barrier to sustainable adoption of AI technologies in U.S. clinical care. A 2025 analysis (PubMed 42128881) finds that the Centers for Medicare & Medicaid Services (CMS) currently reimburses AI-enabled technologies through a fragmented set of procedural codes, add-on payments, and legacy payment models — none of which were designed to support the complexity or workflow integration of clinical AI. This fragmentation creates structural misalignments that limit adoption, particularly in resource-constrained settings. The paper identifies key policy problems: unclear coverage pathways, payment models misaligned with clinical value, and insufficient mechanisms to promote equitable adoption across diverse healthcare settings. The risk of continuing to rely on these approaches includes underinvestment in high-value AI tools and the perpetuation of access disparities between well-resourced and under-resourced health systems. Proposed solutions include clearer coverage pathways, value-aligned payment models that reward demonstrated clinical outcomes rather than procedural volume, and dedicated mechanisms to incentivize adoption in safety-net and rural settings. The authors argue that aligning reimbursement with clinical value is essential not only for financial sustainability but to ensure AI tools improve care delivery and are equitably integrated into routine clinical practice. This analysis reinforces findings from other economic reviews that the…
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.